|
NMD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.337800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.65170000000182E-05 |
| Normal-vs-Stage2 |
2.100000E-01 |
| Normal-vs-Stage3 |
4.636400E-01 |
| Normal-vs-Stage4 |
4.866600E-01 |
| Stage1-vs-Stage2 |
6.780400E-01 |
| Stage1-vs-Stage3 |
2.752300E-02 |
| Stage1-vs-Stage4 |
1.344870E-03 |
| Stage2-vs-Stage3 |
4.252200E-01 |
| Stage2-vs-Stage4 |
1.284550E-01 |
| Stage3-vs-Stage4 |
2.613000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.220800E-03 |
| Normal-vs-AfricanAmerican |
4.949800E-02 |
| Normal-vs-Asian |
8.332800E-01 |
| Caucasian-vs-AfricanAmerican |
5.80879999999562E-05 |
| Caucasian-vs-Asian |
6.623600E-01 |
| AfricanAmerican-vs-Asian |
3.058200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.636140E-02 |
| Normal-vs-Female |
2.848000E-02 |
| Male-vs-Female |
9.930600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.160200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.161200E-03 |
| Normal-vs-Age(61-80Yrs) |
7.203900E-02 |
| Normal-vs-Age(81-100Yrs) |
8.066400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.655000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.082400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.268600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.135800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.081200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.474400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.534400E-02 |
| Normal-vs-Grade 2 |
4.29690000000038E-05 |
| Normal-vs-Grade 3 |
1.945430E-01 |
| Normal-vs-Grade 4 |
8.875800E-02 |
| Grade 1-vs-Grade 2 |
5.992400E-01 |
| Grade 1-vs-Grade 3 |
1.231580E-01 |
| Grade 1-vs-Grade 4 |
7.756800E-03 |
| Grade 2-vs-Grade 3 |
1.045520E-02 |
| Grade 2-vs-Grade 4 |
5.9083999999987E-05 |
| Grade 3-vs-Grade 4 |
1.582000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.34709998711458E-09 |
| Normal-vs-ccB subtype |
9.126800E-01 |
| ccA subtype-vs-ccB subtype |
1.74159999755119E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.042600E-03 |
| Normal-vs-N1 |
5.847400E-01 |
| N0-vs-N1 |
1.806230E-01 |
|
|
